Aims: Pyoderma, predominantly associated with Staphylococcus pseudintermedius, is a common skin infection of dogs that typically requires long-lasting treatments, complicated by increasing antimicrobial resistance. To investigate new treatment strategies, we aimed at establishing a dog model of pyoderma that closely mimics the natural disease. Methods and Results: We inoculated six laboratory beagles with a methicillinsusceptible strain of S. pseudintermedius. One millilitre of approximately 10 7 , 10 8 , 10 9 CFU per ml was topically applied onto clipped and tape stripped area of dog skin, which was then treated with a dermaroller (microneedle size: 500 lm) immediately after administration. Dogs were monitored daily, suspect pustules were cultured for S. pseudintermedius and evaluated by cytological and histopathological methods. After 24 h, all dogs developed papules and pustules at all three bacterial inoculation sites, which worsened over the next 48 h. Cytological samples of all skin lesions revealed neutrophils with intracellular cocci. Histopathology confirmed subcorneal neutrophilic pustular dermatitis with intralesional cocci and acantholytic keratinocytes, consistent with superficial pyoderma. Staphylococcus pseudintermedius was isolated from pustules of all dogs and confirmed to be the inoculating strain. The results were replicated in all dogs after a wash out period of 6 weeks.
Introduction
Canine pyoderma is a common and troublesome disease veterinarians deal with on a daily basis. Repeated treatments are often required in recurrent cases. Because of the increase in antibiotic resistance, pyoderma represents a growing treatment challenge (Beck et al. 2012; Beever et al. 2015) . Staphylococcus pseudintermedius, a Grampositive, coagulase-positive organism, is the most commonly isolated organism from canine pyoderma cases (Bloom 2014) . Based on the depth of the infection, canine pyodermas have been classified into surface, superficial and deep infections (Beco et al. 2013) . Superficial pyodermas such as impetigo and exfoliative superficial pyoderma are characterized by the presence of papules, pustules and epidermal collarettes. Classic treatment options for canine pyoderma are locally or systemically applied antibiotics. However, with the worldwide increase in the prevalence of resistance to commonly used antimicrobial agents and the steady increase in the prevalence of methicillin resistant S. pseudintermedius strains (MRSP) (Beck et al. 2012; Beever et al. 2015) , treatment can become a challenge. Additionally, there is evidence that a repetitive treatment of recurrent cases of pyoderma in dogs might favour the development of MRSP strains (Huerta et al. 2011) .
To investigate new treatment and prevention strategies for canine pyoderma, including those specifically targeting S. pseudintermedius, there is a need for a canine model that mimics the naturally occurring disease. To address this need, we aimed to establish a dog model of pyoderma that would clinically and histologically resemble that of the natural disease. Herein, we describe a robust and reproducible dog model of pyoderma that could present a suitable tool to test new preventative and treatment strategies for canine pyoderma.
Materials and methods

Study design
This study was divided in two phases: In phase 1, we treated six dogs topically with different concentrations of a specific S. pseudintermedius strain and observed the development of infectious lesions over time. In phase 2, we treated the same six dogs with 10 8 and 10 9 CFU per ml S. pseudintermedius after performing different degrees of skin barrier impairment. There was treatment-free interval of 6 weeks between the two settings.
Study subjects
All procedures in this experiment were approved by the NC State University Institutional Animal Care and Use Committee prior to study initiation. Six laboratory beagles, three intact males and three spayed females, were used for the study. The median age was 1Á1 years (range 0Á8-1Á8) and the median weight was 9Á1 kg (range 7Á8-11Á1). The dogs were kept in a BSL-2 facility with access limited to only people directly involved in the study.
Materials
Staphylococcus pseudintermedius strain A S. pseudintermedius strain (13-13613), previously isolated from a dog with naturally occurring superficial pyoderma, was used to inoculate the uninfected dogs in this study. This strain was chosen because of its well-characterized antibiotic susceptibility profile and the presence of agrD, a gene important in staphylococcal quorum-sensing. The antibiotic susceptibility was determined using broth microdilution methods (Vitek2 â ; Biomeriux, Marcy-I'Etoile, France) and interpreted using CLSI (2015) guidelines. The strain was susceptible to oxacillin and lacked the mecA gene, and was therefore considered methicillin-susceptible.
Prior to inoculation, the S. pseudintermedius strain was removed from the freezer and grown overnight on 5% Columbia sheep blood agar (CBA; Remeal, Lenexa, KS) in 5% CO 2 at 37°C. The next day, pure colonies were selected and grown in a shaking incubator overnight at 37°C in 10 ml Luria broth (LB; Sigma, St Louis, MO).
Staphylococcus pseudintermedius challenge One millilitre of overnight inoculum was serially diluted in 9 ml of LB to achieve concentrations of approximately 10 7 , 10 8 and 10 9 CFU per ml. An aliquot from each of these concentration treatment groups was obtained prior to challenge, serially diluted in sterile phosphate-buffered saline (Fisher Scientific, Waltham, MA, USA), and plated in triplicate onto CBA to confirm the starting concentration. The inoculum was then held at 4°C until 1 ml of each concentration of S. pseudintermedius was topically applied to a clipped and tape stripped (OfficeMax, Naperville, IL) dog skin in three, 333 ll intervals. After each application, the site was treated with a dermaroller (microneedle size: 500 lm; M.T. Roller, Pearl Enterprises, Lakewood, NJ). The dermaroller was applied with no additional pressure onto the skin, moving once horizontally and once vertically over the treatment area. Each dog had four 4 9 4 cm treatment areas for each bacterial concentration (10 7 , 10 8 and 10 9 CFU per ml) and the negative control (sterile, uninoculated LB).
Study phase 1: Evaluation of lesions, cytological samples, histological samples and re-isolation of Staphylococcus pseudintermedius
Dogs were evaluated on a daily basis for development of lesions and photos were taken from all treated areas (including negative control areas). Dogs in which the skin lesions were deemed too severe (as observed by a boardcertified dermatologist) were administered oral cephalexin (25 mg kg À1 , twice daily) for 4 weeks.
Intact pustules were opened with a sterile needle and cytological touch-prep samples were taken from three dogs, which had not been biopsied for histology (see below), 48 h after bacterial challenge. Slides were stained with Diff Quick and evaluated at 109 and 1009 magnification. In addition, swabs from intact pustules from each dog were submitted to the Clinical Microbiology Laboratory for aerobic culture and susceptibility in Port-A-Cul tube (BD, Franklin Lakes, NJ). Swabs were plated onto CBA and an inoculating loop was used to streak for isolated colonies. Plates were incubated overnight in 5% CO 2 at 37°C. Presumptive S. pseudintermedius colonies were ensured to be pure and were identified using an automated microbial identification system (Vitek MS; Biomeriux). Isolates were frozen at À80°C in 25% glycerol for future characterization.
Pulsed-field gel electrophoresis (PFGE) was used to characterize the genetic type of recovered S. pseudintermedius isolates from pustules acquired during the two study phases and from the nares and skin of participants (second phase only). Methods were in accordance with PulseNet protocol for Staphylococcus aureus (PulseNet; CDC, http://www.cdc.gov/mrsa/pdf/ar_mras_PFGE_s_a ureus.pdf). Briefly, the strains were each digested with the restriction enzyme SmaI for 4 h. Salmonella serotype Branderup strain H9812 was used as a control. The plugs were run in a 1% SeaKem Gold (Lonza, Rockland, ME, USA) agarose gel in 0Á5X TBE running buffer (Fisher) for 21 h. Gel Doc XR (Bio-Rad, Hercules, CA) was used to image the gels and PFGE banding patterns were normalized and evaluated using BioNumerics software (Applied Maths Inc., Austin, TX). Isolates displaying 100% Dice similarity were considered to be the same PFGE type.
For histopathology, three dogs were sedated using 10 lg kg À1 of dexmedetomidine intraveneously (Dexdomitor; Zoetis, NY, NY) and 8 mm punch biopsies were taken after infiltration anaesthesia with 2% lidocaine (Hospira, Lake Forest, IL). Biopsies were collected from pustules present in the treated areas as well as from areas exposed to medium only, the tape strip and dermaroller, but not inoculated by the bacteria (negative control). The biopsy sites were sutured and sedation was reversed with atipamezole (Zoetis, Kalamazoo, MI). After fixation in 10% neutral buffered formalin, skin biopsy samples were processed routinely for histology and 5 lm paraffin sections were stained with haematoxylin and eosin and reviewed by a veterinary pathologist (K.L.).
Study phase 2: Evaluation of different barrier impairment procedures
To confirm the model's repeatability and to further characterize the role of different barrier impairment procedures on development of clinical disease, a challenge treatment procedure was repeated in all dogs after a wash out period of 6 weeks. Prior to the second inoculation, swabs were collected from the nares and nonlesional skin on the lateral thorax of each dog (n = 6) and cultured for S. pseudintermedius as described above; all isolates were saved for further evaluation. In the second challenge, S. pseudintermedius was applied as described above with 1 ml of 10 8 CFU per ml bacterial inoculum on the left side (treatment area of 50 cm 2 ) and 10 9 CFU per ml on the right side (treatment area of 50 cm 2 ). Each field was split into four quarters: the upper left quarter was just clipped, the upper right quarter clipped and tape stripped, the lower left quarter was clipped and treated with the dermaroller and the lower right quarter was treated with clipping, tape strips and dermaroller. Again, once pustules formed, swabs were collected and cultured for S. pseudintermedius. Three colonies per pustule were streaked for purity and saved in 25% glycerol at À80°C for further characterization.
Results
Study phase 1: Evaluation of lesions, cytological samples, histological samples and re-isolation of S. pseudintermedius All six dogs developed lesions in a concentration dependent manner in the first experiment (Fig. 1) . The lesions started as small, erythematous papules beginning 24 h after treatment with rapid transformation to pustules. These lesions were more severe after 48-96 h (Fig. 2) . The pustules progressed to crusts and epidermal collarettes. Purulent exudate was detected upon removal of the crusts for up to 1 week postinoculation. With time, there was evidence of a spontaneous healing characterized by disappearance of the crusts and temporary increase in the scaling. In four dogs, the lesions resolved spontaneously in 2 weeks. In two dogs, however, the lesion severity observed 96 h postinoculation warranted a treatment with oral cephalexin (25 mg kg À1 twice daily) for 28 days. All papules, pustules, crusts and epidermal collarettes resolved within 20 days after initiation of this treatment. Cytology samples from intact pustules taken 48 h after application of the bacterial inoculum revealed suppurative inflammation with intracellular cocci (Fig. 3) . Staphylococcus pseudintermedius was isolated and identified from pustules of all dogs. Skin biopsies from three dogs in phase 1 revealed subcorneal neutrophilic pustules (Fig. 4) that contained bacterial cocci, acantholytic keratinocytes and degenerate neutrophils. Pustules were bordered on the deep margin by mild intercellular oedema (spongiosis). In the dermis, mild, neutrophilic, perivascular dermatitis was accompanied by mild dermal oedema. Skin lesions were not observed in biopsies from controlinoculated sites (sterile broth and dermaroller treated) from the same three patients.
Genotyping using PFGE confirmed the inoculating strain was recovered from the associated pustules (Fig. 5 ).
Study phase 2: Evaluation of different barrier impairment procedures
The second inoculation of all dogs resulted in skin lesions comparable to those observed in the first experiment. However, four out of six dogs showed a clear increase in severity. The severity of the lesions correlated directly with the degree of the skin barrier impairment. The clipper only skin preparation produced a milder lesion than the clipper and tape stripped skin. The clipper and tape strip preparation was less severe than the clipper and dermaroller, which was still less than the treatment of clipper and tape strip and dermaroller (Fig. 6) . Again, PFGE revealed isolation of the inoculating strain in all but one instance, where a second S. pseudintermedius strain was isolated from one pustule (data not shown). In three of the four dogs where S. pseudintermedius was isolated from the nasal swab, a differing pulsotype from the inoculating strain was recovered. To allow for rapid resolution of the infection in the phase 2, all dogs were treated with cephalexin 96 h after bacterial challenge. Pulsed-field gel electrophoresis (PFGE) was used to characterize the recovered Staphylococcus pseudintermedius isolates from pustules acquired during the two study phases. PFGE confirmed that the re-isolated strain from the dogs was identical to the inoculating strain (13613).
Discussion
Although pyoderma due to S. pseudintermedius is a disease frequently seen particularly in dogs suffering from atopic dermatitis, to the author's knowledge, there are no published data about modelling this challenging disease in dogs. Most dogs in this study underwent spontaneous resolution and cleared the infection themselves. This clearly will have major implications if the model is used for therapeutic testing of new drugs. For example, if a new antimicrobial is tested using this model, it would not be possible to determine if the infection was destined to resolve anyway. Hence, great care would need to be taken in study design. The model would be very valuable for assessing prophylactic treatments that could be compared to a control product, but treatment trials would need to be carefully designed in terms of study numbers and outcomes in order to get meaningful results. According to a recent French publication, 16Á9% of isolated S. pseudintermedius from patient dogs in 2010, were MRSP (Haenni et al. 2014) . Another study reported 40Á5% of isolated S. pseudintermedius were MRSP in a dermatological referral centre in Canada (Beck et al. 2012) . In Germany, 7-8% of isolated S. pseudintermedius have been described as MRSP (Ruscher et al. 2009; Nienhoff et al. 2011) . And in China methicillin resistance prevalence ranges between 13% to 48% in S. pseudintermedius isolated between 2007 and 2009 (Feng et al. 2012 Wang et al. 2012) . Thus, MRSP plays a particular role in pyoderma infection and seems to increase in frequency (Beck et al. 2012; Beever et al. 2015) .
Current discussions about the prudent use of antibiotics make it unlikely that new antibiotics will be available soon in veterinary medicine, particularly antibiotics effective against multi-drug resistant strains (Simon 2015) . Thus, new strategies, like specific vaccination strategies or antiseptic treatments have to be established for dogs suffering from pyoderma. However, up to now, no dog model of pyoderma has been published, which recreates characteristic clinicopathological features of the naturally occurring disease, and this limits the researchers' ability to adequately evaluate new therapeutic opportunities.
Our results demonstrate experimental recreation of classical skin lesions of bacterial pyoderma in dogs. Clinically, a superficial pustular dermatitis consistently developed that is a well-recognized form of S. pseudintermedius induced superficial pyoderma. Bacterial culture, cytology and histopathology confirmed the presence of subcorneal pustules that contained neutrophils, bacterial cocci and acantholytic keratinocytes, which are all key diagnostic features (Bloom 2014) . The presence of acantholytic keratinocytes supports production of exfoliative toxins by S. pseudintermedius (Iyori et al. 2010 (Iyori et al. , 2011 . Exfoliative toxins cleave keratinocyte desmosomes to induce acantholysis and promote pustule formation and are thought to be a key mechanism causing skin lesions in naturally occurring superficial pyoderma (Iyori et al. 2010 (Iyori et al. , 2011 .
It has been described that a certain impairment of barrier function is necessary to induce pyoderma in dogs (Bloom 2014 ), which are not predisposed for pyoderma. Factors predisposing pyoderma are hypersensitivity (food allergy, atopic dermatitis), ectoparasites like Sarcoptes sp., (local) immune suppression, hypothyrioidism or cornification abnormalities (Bloom 2014) . As our laboratory beagles had none of these predisposing factors, we decided to create barrier injury directly at the time of bacterial slurry inoculation. To accomplish this, we performed tape stripping, which removes stratum corneum, induces mild inflammation and promotes bacterial colonization (Wanke et al. 2013) , and we created microperforations of the stratum corneum/upper epidermal layers using a dermaroller. The treated skin areas were also clipped with an electric razor, which can induce additional microtrauma. With the second set of experiments, results demonstrate that the more invasive barrier disruption procedures resulted in the most severe induction of pyoderma skin lesions (Fig. 6) .
Taken together, these results demonstrate the feasibility of establishing a dog model of superficial pyoderma, which could be modified according to specific needs. This model can be used for basic research (e.g. elucidating the role of exfoliative toxin in lesion development) as well as for evaluation of new treatment options (innovative local or systemic treatment options) with a primary emphasis on preventative strategies. 
